Cisatracurium (as besylate) 20mg-10mL Solution for injection or infusion_Nimbex_Glaxosmithkline_4917

Medicines Control Authority of Zimbabwe Follow

Medicines Control Authority of Zimbabwe @mcazofficial ·

15 Nov

HAPPENING NOW

A consultative stakeholder meeting to review amendments to the DANGEROUS DRUGS (PRODUCTION OF CANNABIS FOR MEDICINAL AND SCIENTIFIC USE) REGULATIONS, 2018, STATUTORY INSTRUMENT 62 OF 2018.

Reply on Twitter 1857333573696778601 Retweet on Twitter 1857333573696778601 1 Like on Twitter 1857333573696778601 7 Twitter 1857333573696778601

Medicines Control Authority of Zimbabwe @mcazofficial ·

11 Nov

As #MedSafetyWeek concludes, we still need your help to make medicines safer for everyone.

If you suspect you’re experiencing a side effect from a medicine, remember to submit a report to your national regulatory authority or speak with a healthcare professional ✅

Reply on Twitter 1855868062047563839 Retweet on Twitter 1855868062047563839 1 Like on Twitter 1855868062047563839 6 Twitter 1855868062047563839

Medicines Control Authority of Zimbabwe @mcazofficial ·

10 Nov

Reporting #Sideeffects helps make medicines safer for everyone. Play your part and report all side effects to the MCAZ
#MedSafetyWeek

Reply on Twitter 1855608851380228277 Retweet on Twitter 1855608851380228277 1 Like on Twitter 1855608851380228277 6 Twitter 1855608851380228277

Medicines Control Authority of Zimbabwe @mcazofficial ·

10 Nov

READ: The MCAZ encourages members of the public to always report any suspected side effects they may experience from taking medicines, vaccines and/or using medical devices, to help make medicines safer for everyone

More on: https://www.mcaz.co.zw/wp-content/uploads/2024/11/MEDIA-RELEASE-MedSafetyWeek_Rvd.pdf

#MedSafetyWeek
#PatientSafety

Reply on Twitter 1855532598845751476 Retweet on Twitter 1855532598845751476 5 Like on Twitter 1855532598845751476 8 Twitter 1855532598845751476

Cisatracurium (as besylate) 20mg-10mL Solution for injection or infusion_Nimbex_Glaxosmithkline_4917

QUICK LINKS

FACEBOOK FEED

TWITTER FEED

CONTACT US